-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Barclays Adjusts Price Target on Amneal Pharmaceuticals to $4 From $7, Keeps Overweight Rating

--Barclays Adjusts Price Target on Amneal Pharmaceuticals to $4 From $7, Keeps Overweight Rating

MT Newswires · 03/10/2023 03:23